HeartWare Updates Status Of Battles On Several Fronts

HeartWare is counting on its established HVAD technology to carry it through a difficult period as it struggles to relaunch the clinical trial of the MVAD miniaturized ventricular assist device.

More from Archive

More from Medtech Insight